Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by slaveonfoolson Jul 16, 2013 7:46am

45 Views

Post# 21609551

RE:I SAY BEGGINING OF SEPTEMBER IS SHOWTIME !

With the right news, all eyes will be on SBM.. look at NCI CXO ZEN, etc. There's still tonnes of action around right now under the right circumstances. I haven't heard anything so you may be right if you've heard Sept. But I'm gunna hope for something sooner.

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale